Terms: = Uterine cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Treatment
27 results:
1. Advances in the application of immune checkpoint inhibitors in gynecological tumors.
Zou Y; Xu Y; Chen X; Zheng L
Int Immunopharmacol; 2023 Apr; 117():109774. PubMed ID: 37012881
[TBL] [Abstract] [Full Text] [Related]
2. Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers.
Zheng X; Gu H; Cao X; Pan B; Xiang H; Ju M; Xu S; Zheng M
Front Immunol; 2023; 14():1113369. PubMed ID: 36875089
[TBL] [Abstract] [Full Text] [Related]
3. Highlights into historical and current immune interventions for cancer.
Cole K; Al-Kadhimi Z; Talmadge JE
Int Immunopharmacol; 2023 Apr; 117():109882. PubMed ID: 36848790
[TBL] [Abstract] [Full Text] [Related]
4. Generation and Functional Characterization of PLAP car-T Cells against Cervical cancer Cells.
Yekehfallah V; Pahlavanneshan S; Sayadmanesh A; Momtahan Z; Ma B; Basiri M
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139135
[TBL] [Abstract] [Full Text] [Related]
5. Factors associated with cervical cancer screening among women aged 25-60 years in Lao People's Democratic Republic.
Phaiphichit J; Paboriboune P; Kunnavong S; Chanthavilay P
PLoS One; 2022; 17(4):e0266592. PubMed ID: 35390098
[TBL] [Abstract] [Full Text] [Related]
6. Expression profiling of lncRNAs and mRNAs in placental site trophoblastic tumor (PSTT) by microarray.
Gan J; Chen Z; Feng X; Wei Z; Zhang S; Du Y; Xu C; Zhao H
Int J Med Sci; 2022; 19(1):1-12. PubMed ID: 34975294
[TBL] [Abstract] [Full Text] [Related]
7. The Asian perspective on HIFU.
Lee KW
Int J Hyperthermia; 2021 Sep; 38(2):5-8. PubMed ID: 34420444
[TBL] [Abstract] [Full Text] [Related]
8. High neutrophil-to-lymphocyte ratio is a predictor of short-term survival for patients with recurrent cervical cancer after radiation-based therapy.
Taguchi A; Nakajima Y; Furusawa A; Yoshino Y; Takao M; Kashiyama T; Kino N; Yasugi T
J Obstet Gynaecol Res; 2021 May; 47(5):1862-1870. PubMed ID: 33611808
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: A systemic review, meta-analysis, and meta-regression of observational studies.
Han X; Liu S; Yang G; Hosseinifard H; Imani S; Yang L; Maghsoudloo M; Fu S; Wen Q; Liu Q
Gynecol Oncol; 2021 Jan; 160(1):351-360. PubMed ID: 33092868
[TBL] [Abstract] [Full Text] [Related]
10. Novel cellular immunotherapy using NKG2D car-T for the treatment of cervical cancer.
Zhang Y; Li X; Zhang J; Mao L
Biomed Pharmacother; 2020 Nov; 131():110562. PubMed ID: 32920508
[TBL] [Abstract] [Full Text] [Related]
11. cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung cancer Antigen-1.
Marcinkowski B; Stevanović S; Helman SR; Norberg SM; Serna C; Jin B; Gkitsas N; Kadakia T; Warner A; Davis JL; Rooper L; Hinrichs CS
J Immunother Cancer; 2019 Aug; 7(1):229. PubMed ID: 31455429
[TBL] [Abstract] [Full Text] [Related]
12. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
[TBL] [Abstract] [Full Text] [Related]
13. cancer-associated retinopathy preceding the diagnosis of cancer.
Hoogewoud F; Butori P; Blanche P; Brézin AP
BMC Ophthalmol; 2018 Nov; 18(1):285. PubMed ID: 30390655
[TBL] [Abstract] [Full Text] [Related]
14. The efficacy of concurrent weekly carboplatin with radiotherapy in the treatment of cervical cancer: A meta-analysis.
Xue R; Cai X; Xu H; Wu S; Huang H
Gynecol Oncol; 2018 Sep; 150(3):412-419. PubMed ID: 29996970
[TBL] [Abstract] [Full Text] [Related]
15. Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines.
Lin Y; Wang W; Wan J; Yang Y; Fu W; Pan D; Cai L; Cheng T; Huang X; Wang Y
Virol J; 2018 Apr; 15(1):65. PubMed ID: 29631630
[TBL] [Abstract] [Full Text] [Related]
16. A Non-Gas-Based Cryotherapy System for the treatment of Cervical Intraepithelial Neoplasia: A Mixed-Methods Approach for Initial Development and Testing.
Cremer M; Paul P; Bergman K; Haas M; Maza M; Zevallos A; Ossandon M; Garai JD; Winkler JL
Glob Health Sci Pract; 2017 Mar; 5(1):57-64. PubMed ID: 28351879
[TBL] [Abstract] [Full Text] [Related]
17. Outcomes of concurrent radiotherapy and weekly paclitaxel/carboplatin therapy in cervical cancer: a retrospective study.
Chikazawa K; Netsu S; Konno R
Eur J Gynaecol Oncol; 2016 Aug; 37(4):511-516. PubMed ID: 29894076
[TBL] [Abstract] [Full Text] [Related]
18. Human Papillomavirus E6 Knockdown Restores Adenovirus Mediated-estrogen Response Element Linked p53 Gene Transfer in HeLa Cells.
Kajitani K; Honda K; Terada H; Yasui T; Sumi T; Koyama M; Ishiko O
Asian Pac J Cancer Prev; 2015; 16(18):8239-45. PubMed ID: 26745067
[TBL] [Abstract] [Full Text] [Related]
19. Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer.
Ramondetta LM; Meyer LA; Schmeler KM; Daheri ME; Gallegos J; Scheurer M; Montealegre JR; Milbourne A; Anderson ML; Sun CC
Gynecol Oncol; 2015 Dec; 139(3):500-5. PubMed ID: 26498912
[TBL] [Abstract] [Full Text] [Related]
20. A preliminary study of genes related to concomitant chemoradiotherapy resistance in advanced uterine cervical squamous cell carcinoma.
An JS; Huang MN; Song YM; Li N; Wu LY; Zhan QM
Chin Med J (Engl); 2013 Nov; 126(21):4109-15. PubMed ID: 24229683
[TBL] [Abstract] [Full Text] [Related]
[Next]
